These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3424386)
1. A comparison of the effects of cisplatin and N-methyliminodiacetato-(1,2-diaminocyclohexane)-platinum(II) on renal function and gentamicin excretion in rats. Engineer MS; Ho DH; Khokhar AR; Newman RA; Bulger RE Toxicology; 1987 Dec; 47(3):307-15. PubMed ID: 3424386 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Engineer MS; Brown NS; Ho DH; Newman RA; Bulger RE Toxicology; 1989 Dec; 59(2):151-62. PubMed ID: 2588264 [TBL] [Abstract][Full Text] [Related]
3. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II). Newman RA; Khokhar AR; Sunderland BA; Travis EL; Bulger RE Toxicol Appl Pharmacol; 1986 Jul; 84(3):454-63. PubMed ID: 3726868 [TBL] [Abstract][Full Text] [Related]
4. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat. Smith MA; Smith JH; Litterst CL; Copley MP; Uozumi J; Boyd MR Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230 [TBL] [Abstract][Full Text] [Related]
5. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats. Engineer MS; Bodey GP; Newman RA; Ho DH Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307 [TBL] [Abstract][Full Text] [Related]
6. Modification of methyliminodiacetato-trans-R,R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody. Rosenblum MG; Murray JL; Stuckey S; Newman RA; Chaney S; Khokhar AR Cancer Chemother Pharmacol; 1990; 25(6):405-10. PubMed ID: 2311167 [TBL] [Abstract][Full Text] [Related]
7. The role of the renin-angiotensin system in cisplatin nephrotoxicity. Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239 [TBL] [Abstract][Full Text] [Related]
8. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats]. Horn U; Härtl A; Neuhaus G; Stöckel U; Schröer HP; Hoffmann H Arch Geschwulstforsch; 1989; 59(4):245-50. PubMed ID: 2802932 [TBL] [Abstract][Full Text] [Related]
9. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats. Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820 [TBL] [Abstract][Full Text] [Related]
10. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat. Smith JH; Smith MA; Litterst CL; Copley MP; Uozumi J; Boyd MR Fundam Appl Toxicol; 1988 Jan; 10(1):45-61. PubMed ID: 3350229 [TBL] [Abstract][Full Text] [Related]
11. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity. Bulacio RP; Torres AM Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842 [TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183 [TBL] [Abstract][Full Text] [Related]
13. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Kawai Y; Taniuchi S; Okahara S; Nakamura M; Gemba M Biol Pharm Bull; 2005 Aug; 28(8):1385-8. PubMed ID: 16079479 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat. de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats. Osman NM; Copley MP; Litterst CL Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145 [TBL] [Abstract][Full Text] [Related]
16. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats. Osman NM; Copley MP; Litterst CL Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763 [TBL] [Abstract][Full Text] [Related]
17. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats. Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493 [TBL] [Abstract][Full Text] [Related]
18. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
20. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Suzuki CA; Cherian MG Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]